Common use of DŮVĚRNOST INFORMACÍ Clause in Contracts

DŮVĚRNOST INFORMACÍ. The Protocol, Study Drug(s), CRFs, and any and all information, data, reports or documents, disclosed to or generated by the Institution or any Study Team members regarding the work performed under this Agreement (other than subject medical records) or which otherwise relates to this Study (“Confidential Information”) belong to Sponsor and shall not be disclosed by the Institution to any third party or be used for any purpose other than the performance of the Study without the prior written consent of Sponsor, during a period of seven (7) years after the termination of the performance of the Agreement. The above obligations of confidentiality shall not apply to the extent Confidential Information:

DŮVĚRNOST INFORMACÍ. The Protocol, Study Drug(s), CRFs, and any and all information, data, reports or documents, disclosed to or generated by the Institution Provider or any Study Team members regarding the work performed under this Agreement (other than subject medical records) or which otherwise relates to this Study (“Confidential Information”) belong to Sponsor and shall not be disclosed by the Institution Provider to any third party or be used for any purpose other than the performance of the Study without the prior written consent of Sponsor, during a period of seven (7) years after the termination of the performance of the Agreement. The above obligations of confidentiality shall not apply to the extent Confidential Information:

DŮVĚRNOST INFORMACÍ. (a) The Protocol, Study Drug(s), CRFs, and any and all information, data, reports or documents, disclosed to or generated by the Institution Site or any Study Team members regarding the work performed under this Agreement (other than subject medical records) or which otherwise relates to this Study (“Confidential Information”) belong to Sponsor and shall not be disclosed by the Institution Site to any third party or be used for any purpose other than the performance of the Study without the prior written consent of Sponsor, during a period of seven (7) years after the termination of the performance of the Agreement. The above obligations of confidentiality shall not apply to the extent Confidential Information:Confidential

DŮVĚRNOST INFORMACÍ. The Protocol, Study Drug(s), CRFs, and any and all information, data, reports or documents, disclosed to or generated by the Institution Site or any Study Team members regarding the work performed under this Agreement (other than subject medical records) or which otherwise relates to this Study (“Confidential Information”) belong to Sponsor and shall not be disclosed by the Institution Site to any third party or be used for any purpose other than the performance of the Study without the prior written consent of Sponsor, during a period of seven fifteen (715) years after the termination of the performance of the Agreement. The above obligations of confidentiality shall not apply to the extent Confidential Information:

DŮVĚRNOST INFORMACÍ. The Protocol, Study Drug(s), CRFs, and any and all information, data, reports or documents, disclosed to or generated by the Institution Site or any Study Team members regarding the work performed under this Agreement (other than subject medical records) or which otherwise relates to this Study (“Confidential Information”) belong to Sponsor and shall not be disclosed by the Institution Site to any third party or be used for any purpose other than the performance of the Study without the prior written consent of Sponsor, during a period of seven (7) years after the termination of the performance of the Agreement. The above obligations of confidentiality shall not apply to the extent Confidential Information:

DŮVĚRNOST INFORMACÍ. The Protocol, Study Drug(s), CRFs, and any and all information, data, reports or documents, disclosed to or generated by the Institution Site or any Study Team members regarding the work performed under this Agreement (other than subject Study Subject medical records) or which otherwise relates to this Study (“Confidential Information”) belong to Sponsor and shall not be disclosed by the Institution Site to any third party or be used for any purpose other than the performance of the Study without the prior written consent of Sponsor, during a period of seven (7) years after the termination of the performance of the Agreement. The above obligations of confidentiality shall not apply to the extent Confidential Information:

DŮVĚRNOST INFORMACÍ. The Protocol, Study Drug(s), CRFs, and any and all information, data, reports or documents, disclosed to or generated by the Institution Site or any Study Team members regarding the work performed under this Agreement (other than subject Study Patient medical records) or which otherwise relates to this Study (“Confidential Information”) belong to Sponsor and shall not be disclosed by the Institution Site to any third party or be used for any purpose other than the performance of the Study without the prior written consent of Sponsor, during a period of seven (7) years after the termination of the performance of the Agreement. The above obligations of confidentiality shall not apply to the extent Confidential Information: